In the second part of my Lab4Tox tour, we moved onto the equipment, and why an impressive-looking COA may prove far less than people think.
Lab4Tox uses a SCIEX Triple Quad 3500 LC–MS/MS system for peptide testing. Identification is based on retention time and at least two MRM transitions, with further confirmation from an isotopically labelled reference or an additional transition. This is standard practice in toxicology and anti-doping, where getting the identity wrong can have serious consequences.
Andrzej was far less convinced by peptide results based only on HPLC with UV or diode-array detection. Those methods can show that a peak appeared at a particular retention time, but they cannot conclusively prove that it belongs to the peptide named on the report. He described one case in which supplier paperwork claimed the expected amount of retatrutide, while his own LC–MS/MS analysis found almost none.
Andrzej's experience with some Chinese suppliers followed a familiar pattern: the first samples contained the declared peptide, although often heavily underdosed, before the quality deteriorated further with later orders. Once challenged, communication with the suppliers reportedly stopped, leaving the European buyers with little practical recourse.
Lab4Tox can also test for trifluoroacetic acid, although nobody has yet requested it. The laboratory has prepared an endotoxin-testing service using a commercial kit, but had not yet tested a customer sample. For heavy metals, their view was that testing should follow the manufacturing process. A standard panel may look reassuring while missing the metal most likely to be present; nickel was highlighted as particularly relevant where it has been used during protein purification.
GC–MS remains one of the laboratory’s main forensic tools, including for measuring alcohol in blood. Unknown substances can be separated from mixtures using fraction collection, then investigated using high-resolution mass spectrometry and NMR. It is powerful work, but also slow and expensive.
We finished by discussing reports of benzyl alcohol in lyophilised peptide vials. Andrzej said it would be easy to detect by GC–MS, but could be missed during targeted LC–MS/MS peptide testing because that method is looking specifically for the peptide, not everything else inside the vial. Andrzej considered its use as an antimicrobial preservative plausible and argued that microbiological contamination may be one of the most serious risks in the entire grey-market peptide supply.